Healthcare Finance Group announced that based on information provided by Thomson Reuters, HFG was ranked as the #1 U.S. Healthcare ABL bookrunner in 2013 for middle-market healthcare deals under $500 million that included an ABL tranche.

As shown below, HFG’s market share of $485.0 million or 26% of the total was based on the aggregate healthcare ABL related tranche amount of $1,881.9 million for all 16 bookrunners that were included in the report.